93 related articles for article (PubMed ID: 18931565)
1. [Cardiac toxicity and edema].
Takeuchi S; Sakai H
Gan To Kagaku Ryoho; 2008 Oct; 35(10):1654-8. PubMed ID: 18931565
[TBL] [Abstract][Full Text] [Related]
2. Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study.
Bengala C; Zamagni C; Pedrazzoli P; Matteucci P; Ballestrero A; Da Prada G; Martino M; Rosti G; Danova M; Bregni M; Jovic G; Guarneri V; Maur M; Conte PF;
Br J Cancer; 2006 Apr; 94(7):1016-20. PubMed ID: 16570045
[TBL] [Abstract][Full Text] [Related]
3. Trastuzumab-associated cardiotoxicity.
Keefe DL
Cancer; 2002 Oct; 95(7):1592-600. PubMed ID: 12237930
[TBL] [Abstract][Full Text] [Related]
4. Beyond chemotherapy--demystifying the new 'targeted' cancer treatments.
Dear R; Wilcken N; Shannon J
Aust Fam Physician; 2008; 37(1-2):45-9. PubMed ID: 18239753
[TBL] [Abstract][Full Text] [Related]
5. [Cardiac dysfunction induced by trastuzumab].
Campone M; Bourbouloux E; Fumoleau P
Bull Cancer; 2004 Nov; 91 Suppl 3():166-73. PubMed ID: 15899624
[TBL] [Abstract][Full Text] [Related]
6. Cardiac toxicity from systemic cancer therapy: a comprehensive review.
Curigliano G; Mayer EL; Burstein HJ; Winer EP; Goldhirsch A
Prog Cardiovasc Dis; 2010; 53(2):94-104. PubMed ID: 20728696
[TBL] [Abstract][Full Text] [Related]
7. Reversing resistance to targeted therapy.
Vidal L; Attard G; Kaye S; De Bono J
J Chemother; 2004 Nov; 16 Suppl 4():7-12. PubMed ID: 15688600
[TBL] [Abstract][Full Text] [Related]
8. Clinical cardiac tolerability of trastuzumab.
Perez EA; Rodeheffer R
J Clin Oncol; 2004 Jan; 22(2):322-9. PubMed ID: 14722042
[TBL] [Abstract][Full Text] [Related]
9. Trastuzumab beyond progression: is the risk of cardiac toxicity really not increased?
Morabito A; Piccirillo MC; De Maio E; Di Maio M; Perrone F
J Clin Oncol; 2009 Sep; 27(27):e123; author reply e124-5. PubMed ID: 19687322
[No Abstract] [Full Text] [Related]
10. Imatinib mesylate (Gleevec) induced unilateral optic disc edema.
DeLuca C; Shenouda-Awad N; Haskes C; Wrzesinski S
Optom Vis Sci; 2012 Oct; 89(10):e16-22. PubMed ID: 22960614
[TBL] [Abstract][Full Text] [Related]
11. Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes.
Gianni L; Salvatorelli E; Minotti G
Cardiovasc Toxicol; 2007; 7(2):67-71. PubMed ID: 17652806
[TBL] [Abstract][Full Text] [Related]
12. Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer.
Suter TM; Cook-Bruns N; Barton C
Breast; 2004 Jun; 13(3):173-83. PubMed ID: 15177418
[TBL] [Abstract][Full Text] [Related]
13. [Indications for Herceptin in breast cancer treatment].
Beuzeboc P
Gynecol Obstet Fertil; 2004 Feb; 32(2):164-72. PubMed ID: 15123142
[TBL] [Abstract][Full Text] [Related]
14. Trastuzumab versus lapatinib: the cardiac side of the story.
Azim H; Azim HA; Escudier B
Cancer Treat Rev; 2009 Nov; 35(7):633-8. PubMed ID: 19640652
[TBL] [Abstract][Full Text] [Related]
15. [Appearance of skin and nail toxicity in patients with breast cancer who underwent trastuzumab-containing chemotherapy].
Adachi S; Yoshimura T; Matsuoka T; Okada K; Yasuda T; Kamei K
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1453-6. PubMed ID: 21918340
[TBL] [Abstract][Full Text] [Related]
16. Intramuscular edema as a complication of treatment with imatinib.
Shimazaki C; Ochiai N; Uchida R; Fuchida SI; Okano A; Ashihara E; Inaba T; Fujita N; Nakagawa M
Leukemia; 2003 Apr; 17(4):804-5. PubMed ID: 12682642
[No Abstract] [Full Text] [Related]
17. Ocular side effects in chronic myeloid leukemia patients treated with imatinib.
Breccia M; Gentilini F; Cannella L; Latagliata R; Carmosino I; Frustaci A; Alimena G
Leuk Res; 2008 Jul; 32(7):1022-5. PubMed ID: 18061664
[TBL] [Abstract][Full Text] [Related]
18. Tomorrow's targeted therapies in breast cancer patients: what is the risk for increased radiation-induced cardiac toxicity?
Magné N; Chargari C; MacDermed D; Conforti R; Védrine L; Spano JP; Khayat D
Crit Rev Oncol Hematol; 2010 Dec; 76(3):186-95. PubMed ID: 20138541
[TBL] [Abstract][Full Text] [Related]
19. [Cardiologic follow up of an oncologic patient].
Zaugg Longchamp D; Zaman K; Aebischer N
Rev Med Suisse; 2010 Jun; 6(251):1133-4, 1136-9. PubMed ID: 20572357
[TBL] [Abstract][Full Text] [Related]
20. Cardiotoxicity associated with trastuzumab treatment of HER2+ breast cancer.
Fiúza M
Adv Ther; 2009 Jul; 26 Suppl 1():S9-17. PubMed ID: 19669637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]